CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for G9Pharma Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

G9Pharma Co Ltd
90, Sagimakgol-ro, Jungwon-gu
Phone: +82 317406800p:+82 317406800 SEONGNAM, 13216  South Korea Fax: +82 317410050f:+82 317410050
This company is no longer actively traded on any major stock exchange.
Business Summary
G9Pharma Co Ltd, formerly Kolen Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of aspherical optical lenses. The Company manufactures and sells lenses for camera optics and lenses for application optics. The Company's products are used in cell phone lenses, fingerprint recognition, smart wearable products, among others. In additional, the Company is engaged in the business of supplying vaccines, developing antibody drugs, developing protein products and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202312/31/2022Yes----

Industries
SIC Code Description
3589 Service industry machinery, not elsewhere classified
3679 Electronic components, not elsewhere classified
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Chan GyuKim 61
Managing Director Sang JuPark 46 6/11/2012 6/11/2012
Assistant Managing Director Gwi WukLee 47
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 333 (As of 12/31/2015)
Outstanding Shares: 4,078,777 (As of 3/31/2023)
Shareholders: 17,980
Stock Exchange: KDQ
Fax Number: +82 317410050


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024